Results 231 to 240 of about 789,217 (259)
Some of the next articles are maybe not open access.

Pathobiology of pulmonary fibrosis

American Journal of Physiology-Lung Cellular and Molecular Physiology, 1990
Pulmonary fibrosis is characterized by an increase in lung matrix and alterations in the numbers and spatial relationships of lung parenchymal cells. The increase in matrix results from a proliferation and “activation” of fibroblasts (FB) with increased production and deposition of matrix macromolecules at sites of lung injury.
openaire   +2 more sources

Pulmonary fibrosis

Medicina Clínica (English Edition), 2016
Luis, Gómez Carrera   +1 more
openaire   +2 more sources

Pulmonary Fibrosis

Annals of Internal Medicine, 1977
R A, DeRemee, H A, Andersen
openaire   +2 more sources

Macrophages and Pulmonary Fibrosis

Current Molecular Medicine
Most chronic respiratory diseases often lead to the clinical manifestation of pulmonary fibrosis. Inflammation and immune disorders are widely recognized as primary contributors to the onset of pulmonary fibrosis. Given that macrophages are predominantly responsible for inflammation and immune disorders, in this review, we first focused on the role ...
Shengjun, Chen   +2 more
openaire   +2 more sources

The Myofibroblast in Pulmonary Fibrosis

Chest, 1983
J N, Evans   +4 more
openaire   +2 more sources

Epigenetics of Pulmonary Diseases

Medical Epigenetics, 2021
Narasaiah Kolliputi
exaly  

Human pulmonary fibrosis

Virchows Archiv A Pathological Anatomy and Histology, 1977
J C, Belton, N, Crise
openaire   +2 more sources

Pulmonary Complications in Cancer Patients

Ca-A Cancer Journal for Clinicians, 1996
Robert J Kaner   +2 more
exaly  

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis

New England Journal of Medicine, 2012
Kevin J Anstrom   +2 more
exaly  

Surgical Management of Pulmonary Metastases

Ca-A Cancer Journal for Clinicians, 1963
E W Wilkins
exaly  

Home - About - Disclaimer - Privacy